There were 96 press releases posted in the last 24 hours and 170,824 in the last 365 days.

3D Cell Culture Market :Global Segmentation, key Players, Applications, Analysis and Forecast 2021

3D cell culture global market is poised to grow at a double digit CAGR to reach $3,702.2 million by 2021

PUNE, INDIA, January 13, 2017 /EINPresswire.com/ -- 3D Cell Culture:

3D cell culture is accepted as a new dimension of cell culture sector in biomedical research field. Cells grown on two-dimensional (2D) substrates do not represent true in-vivo cell environment and lack extracellular components, cell-cell and cell-matrix interactions necessary for differentiation, proliferation and cell-based functions. Hence, now-a-days three-dimensional (3D) cell culture methods are much preferred over 2D models as they provide a matrix support that encourages cells to organize into structures more indicative of the in--vivo environment and help to overcome 2D related shortcomings.Increased use of 3D cell culture systems bring the hope of lowering lead molecule attrition rates but however, these models restricts huge data reproducibility, challenge assay readout systems and do not contain all cells relevant for tumour environment. In addition, the favourable artificial environment created by 3D model enables longer-term dosing experiments for analyzing drug’s cumulative effects.

According to analysis, the 3D cell culture global market is poised to grow at a double digit CAGR to reach $3,702.2 million by 2021. The 3D cell culture market is classified based on types, applications, end-users and geography.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/837486-3d-cell-culture-global-market-forecast-to-2021

The 3D cell culture by technology is segmented into scaffold based platform, scaffold free platform, bioreactors, microchips and hydrogels. Scaffold based platform is sub-segmented into natural scaffold, synthetic scaffold and hybrid composite. Natural scaffold is in-turn classified into protein based biomaterials (collagen, fibrin, silk, gelatin, elastin, keratin, actin and myosin, laminin and vitronectin) and polysaccharide based biomaterials (Agarose, alginate, hyaluronan, chitosan, amylase, dextran, cellulose and glycosaminoglycans). The synthetic scaffold is divided into polymer based biomaterials (Poly (lactic-co-glycolic acid), Polyethylene glycol, Polylactic acid, Polyglycolic acid, Polycapro lactone and polystyrene), peptide based biomaterials, ceramic based biomaterials (hydroxyapatite and bioactive glass) and metal based biomaterials (aluminium and titanium).

Scaffold free platform is sub-divided into low attachment surface, hanging drop method and microfluidics. The bioreactors segment consists of spinner flask, rotating wall vessel and perfusion bioreactors. The 3D cell culture consumables section contains cells and tissues, media and sera and reagent.

Further, the 3D culture market by application includes basic research, toxicity and drug safety screening, tissue engineering, stem cell research, drug discovery, gene therapy and cancer research. The 3D cell culture market is segmented into research laboratories and institutes, biotechnology and pharmaceutical industries, hospitals and diagnostic centers and others.

Finally, the 3D cell culture market is classified by geographical regions into North America, Europe, Asia-pacific and Rest of the World.

Access Report @ https://www.wiseguyreports.com/reports/837486-3d-cell-culture-global-market-forecast-to-2021

Table of Content

MAJOR COMPANIES 224
9.1 3D BIOMATRIX 224
9.1.1 OVERVIEW 224
9.1.2 FINANCIALS 224
9.1.3 PRODUCTS PORTFOLIO 225
9.1.4 KEY DEVELOPMENTS 225
9.1.5 BUSINESS STRATEGY 227
9.1.6 SWOT ANALYSIS 228

9.2 3D BIOTEK LLC 229
9.2.1 OVERVIEW 229
9.2.2 FINANCIALS 229
9.2.3 PRODUCT PORTFOLIO 230
9.2.4 KEY DEVELOPMENTS 231
9.2.5 BUSINESS STRATEGY 231
9.2.6 SWOT ANALYSIS 232

9.3 BECTON, DICKINSON AND COMPANY 233
9.3.1 OVERVIEW 233
9.3.2 FINANCIALS 234
9.3.3 PRODUCT PORTFOLIO 237
9.3.4 KEY DEVELOPMENTS 238
9.3.5 BUSINESS STRATEGY 239
9.3.6 SWOT ANALYSIS 240

9.4 CORNING INCORPORATED 241
9.4.1 OVERVIEW 241
9.4.2 FINANCIALS 242
9.4.3 PRODUCT PORTFOLIO 245
9.4.4 KEY DEVELOPMENTS 247
9.4.5 BUSINESS STRATEGY 248
9.4.6 SWOT ANALYSIS 249

9.5 GLOBAL CELL SOLUTIONS, INC 250
9.5.1 OVERVIEW 250
9.5.2 FINANCIALS 250
9.5.3 PRODUCT PORTFOLIO 251
9.5.4 KEY DEVELOPMENTS 252
9.5.5 BUSINESS STRATEGY 252
9.5.6 SWOT ANALYSIS 253

9.6 INSPHERO AG 254
9.6.1 OVERVIEW 254
9.6.2 FINANCIALS 254
9.6.3 PRODUCT PORTFOLIO 255
9.6.4 KEY DEVELOPMENTS 256
9.6.5 BUSINESS STRATEGY 259
9.6.6 SWOT ANALYSIS 260

9.7 LONZA GROUP 261
9.7.1 OVERVIEW 261
9.7.2 FINANCIALS 262
9.7.3 PRODUCT PORTFOLIO 265
9.7.4 KEY DEVELOPMENTS 267
9.7.5 BUSINESS STRATEGY 269
9.7.6 SWOT ANALYSIS 270

9.8 NANO 3D BIOSCIENCES, INC 271
9.8.1 OVERVIEW 271
9.8.2 FINANCIALS 271
9.8.3 PRODUCT PORTFOLIO 272
9.8.4 KEY DEVELOPMENTS 273
9.8.5 BUSINESS STRATEGY 274
9.8.6 SWOT ANALYSIS 275

9.9 NANOFIBER SOLUTIONS 276
9.9.1 OVERVIEW 276
9.9.2 FINANCIALS 276
9.9.3 PRODUCT PORTFOLIO 277
9.9.4 KEY DEVELOPMENTS 278
9.9.5 BUSINESS STRATEGY 278
9.9.6 SWOT ANALYSIS 279

9.10 REPROCELL INCORPORATED 280
9.10.1 OVERVIEW 280
9.10.2 FINANCIALS 280
9.10.3 PRODUCT PORTFOLIO 281
9.10.4 KEY DEVELOPMENTS 282
9.10.5 BUSINESS STRATEGY 283
9.10.6 SWOT ANALYSIS 284

9.11 SIGMA ALDRICH CORPORATION 285
9.11.1 OVERVIEW 285
9.11.2 FINANCIALS 286
9.11.3 PRODUCT PORTFOLIO 289
9.11.4 KEY DEVELOPMENTS 290
9.11.5 BUSINESS STRATEGY 292
9.11.6 SWOT ANALYSIS 293

9.12 THERMO FISHER SCIENTIFIC, INC 294
9.12.1 OVERVIEW 294
9.12.2 FINANCIALS 295
9.12.3 PRODUCT PORTFOLIO 298
9.12.4 KEY DEVELOPMENTS 299
9.12.5 BUSINESS STRATEGY 302
9.12.6 SWOT ANALYSIS 303

…CONTINUED

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=837486

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here